Trial Profile
Drug abuse potential of latrepirdine and alprozolam in recreational polydrug users with sedative experience
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2011
Price :
$35
*
At a glance
- Drugs Alprazolam (Primary) ; Latrepirdine (Primary)
- Indications Alzheimer's disease; Anxiety disorders; Huntington's disease
- Focus Pharmacodynamics
- 10 Mar 2011 New trial record
- 05 Mar 2011 Results presented at the 112th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.